Browse Category

Dividend News News 12 December 2025 - 17 December 2025

Pfizer Stock (PFE) Slips After 2026 Outlook: Guidance, Analyst Forecasts, Dividend Update, and Key Catalysts to Watch on Dec. 17, 2025

Pfizer Stock (PFE) Slips After 2026 Outlook: Guidance, Analyst Forecasts, Dividend Update, and Key Catalysts to Watch on Dec. 17, 2025

Pfizer Inc. (NYSE: PFE) is back in the spotlight on Wednesday, Dec. 17, 2025, as investors digest a fresh set of financial targets for 2026, updated 2025 revenue expectations, and a growing pile of “what matters next” questions about the company’s post-COVID trajectory. In late-morning trading, Pfizer stock hovered around $25.53, down about 3.4% on the day, reflecting a cautious market reaction to management’s outlook and the company’s longer roadmap through a multi-year patent-expiration cycle. Below is what’s moving Pfizer stock today, what the company just guided for 2026, how analysts are framing the setup, and the pipeline and policy
ANZ Share Price Today: Key News, Dividend Outlook and Analyst Forecasts for ANZ Group Holdings (ASX: ANZ) on 17 December 2025

ANZ Share Price Today: Key News, Dividend Outlook and Analyst Forecasts for ANZ Group Holdings (ASX: ANZ) on 17 December 2025

ANZ Group Holdings Limited (ASX: ANZ) is back in the spotlight on 17 December 2025 as investors weigh a busy mix of company updates, banking-sector regulation in New Zealand, and an ongoing governance overhang tied to executive remuneration and misconduct fallout. ANZ shares were around A$36.08 in late trade on 17 December, with the day’s range roughly A$35.88 to A$36.34 (prices delayed). Intelligent Investor ANZ share price snapshot: where ASX:ANZ stands on 17 December 2025 As of late afternoon on 17 December, ANZ’s indicative market data showed: This puts ANZ in a “not cheap, not euphoric” zone: the stock has
Linde plc Stock (LIN) News Today: Analysts Refresh Price Targets as Hydrogen Projects and Dividend Payment Take Focus

Linde plc Stock (LIN) News Today: Analysts Refresh Price Targets as Hydrogen Projects and Dividend Payment Take Focus

Linde plc (NYSE: LIN) stock was modestly lower in Tuesday trading, with shares recently at $416.86 and little changed on the day after a tight range between roughly $414.91 and $419.05. For investors, December 16, 2025 is shaping up less like a “single headline” day and more like a multi-thread narrative: Wall Street research notes are refining their outlooks, hydrogen mobility projects are supplying tangible proof points for the energy-transition thesis, and the calendar is drawing attention to Linde’s imminent dividend payment. What’s driving attention to Linde stock on December 16, 2025 Industrial gases is rarely a “story stock,” but
Linde plc Stock (LIN) Outlook on Dec. 16, 2025: Latest News, Analyst Price Targets, Dividend Date, and What Could Move Shares Next

Linde plc Stock (LIN) Outlook on Dec. 16, 2025: Latest News, Analyst Price Targets, Dividend Date, and What Could Move Shares Next

Linde plc (Nasdaq: LIN)—the world’s largest industrial gases company—heads into mid-December with a familiar mix of investor emotions: respect for a high-quality, cash-generative business… and impatience about when global industrial activity (especially in Europe) will stop acting like it’s stuck in neutral. As of late Monday’s close (Dec. 15), LIN ended at $416.99 and traded around $417 in extended hours, putting the stock in striking distance of where it’s been hovering after a recent pullback. MarketBeat What matters for today’s read is less the last penny of the quote and more the why: fresh analyst notes and investor-meeting takeaways are
National Grid plc Stock (NG.L / NGG): Latest News, Analyst Forecasts, Dividend Outlook and Key Catalysts on 16 December 2025

National Grid plc Stock (NG.L / NGG): Latest News, Analyst Forecasts, Dividend Outlook and Key Catalysts on 16 December 2025

London — 16 December 2025. National Grid plc is back in focus for investors as regulators shape the next phase of Britain’s electricity-transmission buildout, while demand growth narratives—from renewables integration to data-centre and AI-driven load—continue to reshape how “defensive” utility stocks are priced. Below is a roundup of the most relevant news, company updates, analyst forecasts, and market commentary available as of 16.12.2025, plus the key catalysts investors are tracking into 2026. National Grid share price today: where the stock stands on 16 December 2025 National Grid shares on the London market were indicated around 1,128p at the close (Hargreaves
Orla Mining Ltd Stock (ORLA) Update on Dec. 15, 2025: Gold’s Surge, New Dividend, Big-Holder Selling, and What Analysts Are Watching

Orla Mining Ltd Stock (ORLA) Update on Dec. 15, 2025: Gold’s Surge, New Dividend, Big-Holder Selling, and What Analysts Are Watching

Orla Mining Ltd stock is back in the spotlight on Monday, December 15, 2025, as the gold trade heats up and investors weigh a stack of very “2025-coded” catalysts: a newly launched dividend, strong recent free cash flow, fresh Nevada exploration results, and a notable round of large shareholder selling. On the NYSE American, Orla Mining Ltd (ORLA) traded at about $13.64 intraday, after opening higher and moving between roughly $13.44 and $14.20 during the session. The macro backdrop is doing the precious-metals sector no harm. Gold climbed to a more than seven-week high around $4,344/oz, supported by a softer
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Updated: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) Pfizer Inc. (NYSE: PFE) is ending the week in a familiar spot—trading in the mid‑$20s—while investors weigh a high dividend payout against a fast-moving set of catalysts: new oncology data from the Seagen portfolio, a fresh attempt at an oral obesity drug, ongoing cost-cutting, and a looming shift in the U.S. COVID vaccine policy backdrop. Reuters+3StockAnalysis+3Reuters+3 Below is a detailed roundup of the most important Pfizer stock headlines, forecasts, and analyst takes available as of Dec. 14, 2025, plus what to watch next heading into Pfizer’s scheduled 2026
Amphenol (APH) Stock: Why Shares Fell 7% Friday, Weekly Recap, Analyst Forecasts, Dividend Date, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Amphenol (APH) Stock: Why Shares Fell 7% Friday, Weekly Recap, Analyst Forecasts, Dividend Date, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Amphenol Corporation (NYSE: APH) ended a volatile week with a sharp Friday selloff that pulled the stock back toward the low-$130s—despite a still-strong fundamental narrative built around AI-driven data-center demand, record 2025 results, and major acquisition plans. The key question for investors heading into next week: was Friday’s drop a sentiment-driven shakeout tied to the broader “AI trade,” or the start of a deeper re-rating as markets scrutinize valuations across AI-linked industrial and tech supply chains? Investing.com+2Reuters+2 Below is what moved Amphenol stock this week, the most relevant news from the last
OCBC Stock News & Forecast (Dec. 13, 2025): Share Price Near Record Highs as Wealth Fees Surge and 2026 Dividend Debate Heats Up

OCBC Stock News & Forecast (Dec. 13, 2025): Share Price Near Record Highs as Wealth Fees Surge and 2026 Dividend Debate Heats Up

SINGAPORE — As of Dec. 13, 2025, Oversea-Chinese Banking Corporation (OCBC, SGX: O39) is back in the spotlight after a strong late-year run that pushed the stock toward fresh highs. The rally is being powered by a familiar Singapore-bank cocktail: wealth and fee income momentum, a still-resilient domestic backdrop, and investor obsession with dividend “optionality” in 2026—set against the less-fun reality of net interest margin (NIM) compression in a lower-rate world. MarketScreener+2The Business Times+2 Below is a comprehensive roundup of the latest OCBC stock news, analyst forecasts, and the key bull vs. bear arguments shaping sentiment right now. OCBC share
Booking Holdings (BKNG) Stock News on Dec. 12, 2025: Price Action, Dividend, Buybacks, Analyst Targets, and 2026 Travel Outlook

Booking Holdings (BKNG) Stock News on Dec. 12, 2025: Price Action, Dividend, Buybacks, Analyst Targets, and 2026 Travel Outlook

Dec. 12, 2025 — Booking Holdings Inc. (NASDAQ: BKNG) common stock is back in focus as investors balance three powerful forces: resilient global travel demand, aggressive shareholder returns (dividends plus buybacks), and a growing set of legal and regulatory pressures facing online travel platforms. BKNG shares traded around the $5,300 level during Friday’s session, with investors continuing to weigh the company’s strong operating momentum against headline risks tied to pricing transparency, competition policy, and customer-acquisition costs. StockAnalysis BKNG stock price today: where Booking Holdings is trading on Dec. 12, 2025 During the Dec. 12 session, BKNG traded in a narrow
Barrick Mining Corporation Stock (NYSE: B) News, Forecasts & Analysis for Dec. 12, 2025: Dividend, IPO Plans, and What’s Driving the Rally

Barrick Mining Corporation Stock (NYSE: B) News, Forecasts & Analysis for Dec. 12, 2025: Dividend, IPO Plans, and What’s Driving the Rally

Barrick Mining Corporation stock is back in the spotlight on December 12, 2025, as the gold-and-copper heavyweight pushes around fresh highs amid a powerful metals backdrop, an intensified shareholder-return program, and accelerating debate about the company’s future structure. Shares of Barrick Mining (NYSE: B) opened around $43.16 on Friday and have traded near the top of their 12‑month range, with recent reports citing a 12‑month high near $43.94 and a market capitalization in the low‑$70 billion range. MarketBeat For investors who still think in “Barrick Gold” terms: the company rebranded to Barrick Mining Corporation in 2025 and changed its NYSE
Medical Properties Trust (MPW) Stock News on Dec. 12, 2025: Dividend Hike, $150M Buyback, Analyst Targets, and What Investors Are Watching

Medical Properties Trust (MPW) Stock News on Dec. 12, 2025: Dividend Hike, $150M Buyback, Analyst Targets, and What Investors Are Watching

Medical Properties Trust (NYSE: MPW) is back in focus on Dec. 12, 2025 after a sharp post–ex-dividend move, a recently raised payout, and a board-approved $150 million share repurchase plan. Here’s the latest news, forecasts, and analyst analysis shaping MPW stock now. Medical Properties Trust, Inc. (NYSE: MPW ) is ending the week under a fresh spotlight as income investors, short sellers, and REIT watchers weigh a rare combination of signals: a higher dividend , a new share repurchase authorization , and management commentary pointing to improving cash rent collections—against a backdrop of still-elevated leverage and tenant execution risk. Below

Stock Market Today

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
Go toTop